Susceptibility of the elderly to hyponatraemia while using selective serotonin reuptake inhibitors;Susceptibilité du sujet âgé à l'hyponatrémie induite par les inhibiteurs sélectifs du recaptage de la sérotonine

Therapie

Volumn 55, Issue 5, 2000, Pages 597-604

  Fonzo Christe, C ^a   Vogt, N ^a  

^a Hôpital de Géiatrie   (Switzerland)

Author keywords

Depression; Elderly; Hyponatraemia; Selective serotonin reuptake inhibitors; Vasopressin

Indexed keywords

SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1C RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SODIUM ION; TRICYCLIC ANTIDEPRESSANT AGENT; VASOPRESSIN;

DEPRESSION; DISEASE PREDISPOSITION; DRUG SAFETY; FLUID BALANCE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; PATHOPHYSIOLOGY; POLYPHARMACY; PRIORITY JOURNAL; REVIEW; SODIUM BALANCE; VASOPRESSIN RELEASE;

AGE FACTORS; AGED; ANIMALS; COMORBIDITY; DEPRESSION; DISEASE SUSCEPTIBILITY; DRUG INTERACTIONS; HUMANS; HYPONATREMIA; INAPPROPRIATE ADH SYNDROME; KIDNEY; PITUITARY GLAND, ANTERIOR; PREVALENCE; RATS; RISK; SEROTONIN UPTAKE INHIBITORS; VASOPRESSINS; WATER-ELECTROLYTE BALANCE;

EID: 0034530623     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. New antidepressants for old people?
2. Are SSRIs a cost-effective alternative to tricyclics?
3. Discontinuation rates of SSRIs and tricyclic antidepressants: A meta-analysis and investigation of heterogeneity
4. Selective serotonin reuptake inhibitors were less cost-effective for initial treatment than tricyclic antidepressants
5. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: A meta-analysis
6. Selective serotonin reuptake inhibitors in older patients
7. Antidepressants and the elderly: Focus on newer agents
8. Antidepressant-induced hyponatremia
9. Selective serotonin reuptake inhibitors and SIADH
10. Hyponatremia in the elderly
11. Anomalies éctrolytiques chez les personnes âgées
12. Incidence of hyponatremia in elderly patients on hospital admission
13. Hyponatremia in a nursing home population
14. Apparent idiopathic hyponatremia in an ambulatory geriatric population
15. Hyponatremia: A prospective analysis of its epidemiology and the pathogenetic role of vasopressin
16. The syndrome of inappropriate antidiuretic hormone secretion in the elderly
17. Idiopathic syndrome of inappropriate antidiuretic hormone secretion possibly related to advanced age
18. Liquides et électrolytes
19. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: A review of spontaneous reports
20. SSRI-induced SIADH in older people
21. Incidence and risk factors for hyponatremia following treatment with fluoxetine or paroxetine in elderly people
22. Association of SIADH with selective serotonin reuptake inhibitors
23. Incidence of selective serotonin reuptake inhibitor (SSRI) induced hyponatraemia due to the syndrome of inappropriate antidiuretic hormone (SIADH) secretion in the elderly
24. Hyponatraemia associated with the use of selective serotonin re-uptake inhibitors
25. SSRI-induced hyponatraemia
26. More cases of SIADH with fluoxetine
27. Fluoxetine-induced syndrome of inappropriate antidiuretic hormone secretion: A geriatric case report and a review of the literature
28. Association of transient SIADH with sertraline
29. Transient SIADH associated with fluoxetine
30. SIADH associated with sertraline therapy
31. Care of depression in the elderly: Comparative pharmacokinetics of SSRIs
32. Syndrome of inappropriate secretion of antidiuretic hormone in two elderly women with elevated serum fluoxetine
33. Hyponatremia associated with paroxetine
34. Fluoxetine and hyponatremia
35. Nouvelles perspectives de traitement sérotoninergique de la dépression
36. A propos des antidépresseurs récents: Quelques ŕeflexions pharmacologiques
37. Selective serotonin reuptake inhibitors: Pharmacologic profiles and potential therapeutic distinctions
38. Prozac: Panacea or puzzle?
39. Vasopressin and other agents affecting the renal conservation of water
40. Effects of substances influencing brain serotoninergic transmission on plasma vasopressin levels in the rat
41. Vasopressin release after enhanced serotoninergic transmission is not due to activation of the peripheral renin-angiotensin system
42. Neuropharmacological characterization of serotoninergic stimulation of vasopressin secretion in conscious rats
43. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists
44. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males
45. Oxytocin as a possible mediator of SSRI-induced antidepressant effects
46. Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood
47. The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat
48. Vasopressin, oxytocin, corticotrophin-releasing factor, and sodium responses during fluoxetine administration in the rat
49. The effect of a highly specific serotonin agonist on osmoregulated vasopressin secretion in healthy man
50. Chronic fluoxetine treatment reduces hypothalamic vasopressin secretion in vitro
51. Therapeutic effects of serotonin uptake inhibitors in depression
52. Plasma levels of arginine vasopressin elevated in patients with major depression
53. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression
54. Postural hypotension induced by paroxetine
55. Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine
56. Adverse reactions of selective serotonin reuptake inhibitors: Reports from a spontaneous reporting system
57. Drug-induced syndrome of inappropriate antidiuretic hormone secretion
58. Changes in renal function with aging
59. Reduced thirst after water deprivation in healthy elderly men
60. Water balance in elderly people: Is there a deficiency of vasopressin?
61. Age-associated alterations in thirst and arginine vasopressin in response to a water or sodium load
62. Reduced osmotic thirst in healthy elderly men
63. High plasma concentrations of human atrial natriuretic polypeptide in aged men
64. The renin-angiotensin-aldosterone system in normal 85-year-old people
65. Depression in the elderly
66. The association of age and depression among the elderly: An epidemiologic exploration
67. Incidence of major depression in a very elderly population
68. Antidepressant use in the elderly: Association with demographic characteristics, health-related factors, and health care utilization
69. Gender differences in depression: Implications for treatment
70. Risk factors for the development of hyponatremia in psychiatric inpatients